Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
Open Access
- 8 June 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (20) , 18151-18161
Abstract
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysisKeywords
This publication has 44 references indexed in Scilit:
- A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinomaWorld Journal of Surgical Oncology, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised QstatisticsBMC Medical Research Methodology, 2011
- Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning MeetingJournal of Clinical Oncology, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorialBMC Medical Research Methodology, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular CarcinomaAnnals of Surgery, 2007
- Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosisHepatology, 2006
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005